Dermal healing review, 2016
Kleinman and Sosne reviewed thymosin beta-4 in dermal repair and reported faster healing in patients with pressure ulcers and chronic non-healing wounds. Reported in the cited paper.
SourceBack to search
HealingTissue Repair
TB-500
TB-500 is a synthetic fragment reproducing part of the naturally occurring protein Thymosin Beta-4. It is studied for systemic tissue repair, cell migration, wound healing and flexibility, and is widely used in regenerative and athletic recovery research contexts.
- Lowest cost / mg
- $2.60/mg
- at Amino Club
- Vendors listed
- 70
- In stock
- 95 of 99
- listings
- COA reports
- 69
Vendor listings
Compare TB-500 prices.
Show prices as
98 listings · TB-500
In stock5mgseen 4d ago
- Amino ClubLowest $/mg
In stock10mgseen 6d ago
In stock5mgseen 3d ago
In stock5mgseen 4d ago
In stock5mgseen 5d ago
In stock5mgseen 5d ago
In stock5mgseen 4d ago
In stock5mgseen 4d ago
In stock2mgseen 3d ago
In stock10mgseen 3d ago
In stock5mgseen 3d ago
In stock5mgseen 3d ago
In stock5mgseen 4d ago
In stock2mgseen 6d ago
In stock10mgseen 6d ago
In stock5mgseen 4d ago
In stock10mgseen 7d ago
In stock5mgseen 3d ago
In stock5mgseen 3d ago
In stock10mgseen 3d ago
Overview
What is TB-500?
TB-500 is a synthetic fragment reproducing part of the naturally occurring protein Thymosin Beta-4. It is studied for systemic tissue repair, cell migration, wound healing and flexibility, and is widely used in regenerative and athletic recovery research contexts.
- Tissue Repair
- Wound Healing
- Flexibility
- Systemic Recovery
What the research reports
Reported benefits of TB-500
Outcomes described across the published TB-500 literature and ongoing study. Read each as research context rather than a promised personal result.
- 01
Systemic tissue repair work
Thymosin Beta-4 sequesters actin and supports cell migration, which underpins its study in wound repair across several tissue types. Reported in research settings.
- 02
Wound healing study record
A 2016 review described faster dermal repair in patients with pressure ulcers and chronic wounds treated with thymosin beta-4. Reported in research settings.
- 03
Flexibility and mobility study
Often researched for connective tissue pliability after injury. No published human trial has directly measured flexibility as a primary outcome in this indication.
- 04
Inflammation modulation study
Often researched for connective tissue pliability after injury. No published human trial has directly measured flexibility as a primary outcome in this context.
- 05
Cardiac and regenerative study
Preclinical research explores cardiac cell survival and regeneration through reactivation of embryonic repair programmes in adult tissue. Reported in research settings.
Dosage and protocol
How TB-500 is typically studied
Research protocols use 2 to 5 mg weekly during loading, reducing to maintenance afterward. The 4 to 7 day half-life permits once or twice weekly dosing throughout the protocol period.
- Route
- Subcutaneous injection
- Example range
- 2-2.5 mg
- Frequency
- Twice weekly
- Timing
- Once or twice weekly. Some protocols dose every other day during loading.
Clinical evidence
TB-500 clinical evidence summary
The published TB-500 record, labeled by strength so you can see what is settled and what is still emerging.
Anti-aging regeneration review
A 2023 review described cardiac cell survival and regeneration in animal hearts, attributed to reactivation of embryonic repair programmes in adult tissue. Reported in the cited paper.
SourceActin regulation in sepsis
A 2018 paper reported improved sepsis mortality in rats through actin regulation and a reduction in circulating inflammatory mediators during infection. Reported in the cited paper.
SourceInteractions
How TB-500 pairs with other peptides
- BPC-157 peptide
- Synergistic for tissue repair. BPC-157 drives angiogenesis while TB-500 modulates actin and cell migration.
- GHK-Cu peptide
- Often combined in repair blends. Both support remodelling, with GHK-Cu adding collagen and elastin signalling.
- KPV peptide
- No known negative interaction. KPV targets inflammatory signalling while TB-500 targets actin and cell movement.
- Ipamorelin
- No known negative interaction. Growth hormone secretagogues act on a separate axis to actin regulation.
Questions
Frequently asked questions.
What is TB-500?
TB-500 is a peptide compound used in research settings. It is commonly studied for its role in healing, tissue repair, and many researchers compare supplier quality, purity, and testing data before purchasing.
What are the research benefits of TB-500?
TB-500 is often evaluated for its potential influence on signaling pathways, recovery support, and targeted research applications. Research interest varies by peptide, formulation, and study design, so buyers typically review purity, dose, and independent lab verification before choosing a source.
How does TB-500 work?
Like other research peptides, TB-500 is typically studied for how it interacts with specific biological pathways and receptor systems. In practice, the way it is formulated, dosed, and tested matters as much as the compound itself, which is why verified suppliers and transparent COAs are important.
Is TB-500 for research use only?
Yes, products like TB-500 are generally intended for research, laboratory, or educational use and are not marketed as approved human therapeutics. Always follow local laws, lab safety practices, and institutional requirements before handling or studying any peptide.
What should I look for before buying TB-500?
Key checks include verified COA data, peptide form and concentration, supplier reputation, stock status, and cost per mg. Comparing pricing and testing records side-by-side helps reduce the risk of buying an under-tested or misrepresented product.
